少数儿童期肠-脑互动障碍持续至成年:危险因素分析
本研究利用超过6万例覆盖儿童期与成年期的全科医疗记录,分析儿童期诊断的肠-脑互动障碍(DGBI)持续至成年的比例及相关因素。结果显示儿童期肠易激综合征(IBS)和功能性消化不良(FD)分别有11%和20%在成年期重复诊断同一疾病,女性、儿童期胃炎诊断、非甾体抗炎药使用、哮喘、焦虑和抑郁与持续风险相关。作者认为儿童期DGBI在10%-20%患者中持续至成年,管理监测应持续至成年期。
要点
- 儿童期诊断的IBS和FD分别有11%和20%在成年期重复诊断同一疾病。
- 女性(OR 2.02)与IBS持续相关,儿童期胃炎诊断(OR 0.46)为保护因素。
- 儿童期非甾体抗炎药使用(OR 1.31,95%CI 1.09-1.56)是IBS持续的危险因素。
核心结论
- 儿童期DGBI在10%-20%患者中持续至成年,作者建议管理监测应持续至成年期。
- 儿童期诊断焦虑或情绪障碍者应获得特别关注,儿童使用非甾体抗炎药应审慎。
研究设计与样本
- 研究基于全科医疗记录,纳入超过60,000例医疗记录覆盖儿童期与成年期的患者。
- 排除诊断为器质性胃肠疾病的患者,并查询医疗记录中的潜在危险因素。
主要发现
- 儿童期诊断的IBS有11%、FD有20%在成年期重复诊断同一疾病。
- 女性(OR 2.02)与IBS持续相关,儿童期胃炎诊断(OR 0.46)为保护因素。
- 儿童期非甾体抗炎药使用(OR 1.31,95%CI 1.09-1.56)是IBS持续的危险因素。
- 儿童期哮喘诊断(OR 1.30,95%CI 1.00-1.70)是FD持续的危险因素。
- 焦虑与IBS(OR 1.24,95%CI 1.00-1.54)和FD(OR 1.48,95%CI 1.11-1.97)持续相关;抑郁与IBS(OR 1.34,95%CI 1.11-1.62)和FD(OR 1.88,95%CI 1.47-2.42)持续相关。
临床怎么用
- 作者认为儿童期DGBI的管理监测应持续至成年期。
- 作者认为儿童期诊断焦虑或情绪障碍者应获得特别关注。
- 作者认为儿童使用非甾体抗炎药应审慎。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Disorders of gut-brain interaction (DGBIs) may originate in childhood. There are currently limited data on persistence of DGBI into adulthood and risk factors for persistence. Furthermore, there are no data on this question from general practice, where the majority of DGBIs are diagnosed and managed. This study documents the proportion of childhood-diagnosed DGBIs that persisted into adulthood and what factors were associated with persistence. METHODS: General practice records were obtained for more than 60,000 patients whose medical record spanned both childhood and adulthood years. Patients with diagnosed organic gastrointestinal disorder were excluded. Medical records were also interrogated for potential risk factors. RESULTS: Eleven percent of patients with irritable bowel syndrome (IBS) and 20% of patients with functional dyspepsia (FD) diagnosed in childhood had repeat diagnoses of the same condition in adulthood. Female sex (odds ratio [OR] 2.02) was associated with persistence for IBS, while a childhood diagnosis of gastritis (OR 0.46) was risk-protective. Childhood non-steroidal anti-inflammatory drug use (OR 1.31, 95% confidence interval [CI] 1.09-1.56) was a risk factor for persistence in IBS. For FD, a childhood diagnosis of asthma (OR 1.30, 95% CI 1.00-1.70) was a risk factor, as was anxiety for both IBS (OR 1.24, 95% CI 1.00-1.54) and FD (OR 1.48 95% CI 1.11-1.97) with a similar finding for depression for IBS (OR 1.34, 95% CI 1.11-1.62) and FD (OR 1.88 95% CI 1.47-2.42). DISCUSSION: Childhood DGBIs persist into adulthood in 10%-20% of patients, suggesting that management monitoring should continue into adulthood. Those diagnosed with anxiety or mood disorders in childhood should receive particular attention, and prescription of non-steroidal anti-inflammatory drugs in children should be made judiciously.
引用
- Jones MP, Koloski NA, Walker MM, et al. A Minority of Childhood Disorders of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis. Am J Gastroenterol. 2024. PMID: 38483301. doi:10.14309/ajg.0000000000002751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。